Division of Endocrinology and Metabolism, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea.
Copyright © 2019 Korean Diabetes Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported.
AUTHOR CONTRIBUTIONS:
Values are presented as mean±standard deviation or number (%).
BMI, body mass index; WC, waist circumference; LF/TF, leg fat to total fat; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; HOMA-IR, homeostasis model assessment of insulin resistance; WBC, white blood cells; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol; LDL, low density lipoprotein cholesterol; TG, triglyceride; Cr, creatinine; eGFR, estimated glomerular filtration rate; AST, aspartate aminotransferase; ALT, alanine aminotransferase; HTN, hypertension; IFG, impaired fasting glucose; DM, diabetes mellitus; MetS, metabolic syndrome.
aP<0.05 by post hoc analysis when compared with T1 (the lowest tertile), bP<0.05 by post hoc analysis when compared with T2 (the middle tertile), cLog transformed, dCalculated by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation.
Values are presented as odds ratio (95% confidence interval). Model 1: adjusted with age, and sex; Model 2: Model 1+alcohol drink, smoking, exercise; Model 3: Model 2+BMI, waist circumference, systolic blood pressure, fasting blood glucose, estimated glomerular filtration rate, HOMA-IRb, aspartate aminotransferaseb, alanine aminotransferaseb, and total cholesterol.
BMI, body mass index; MetS, metabolic syndrome; HOMA-IR, homeostasis model assessment of insulin resistance; HTN, hypertension; IFG, impaired fasting glucose; DM, diabetes mellitus.
aCentral obesity was defined by ≥90 cm for men and ≥85 cm for women in waist circumference, bLog transformed.
Values are presented as mean±standard deviation or number (%).
BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; HOMA-IR, homeostasis model assessment of insulin resistance; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol; LDL, low density lipoprotein cholesterol; TG, triglyceride; Cr, creatinine; eGFR, estimated glomerular filtration rate; AST, aspartate aminotransferase; ALT, alanine aminotransferase; HTN, hypertension; IFG, impaired fasting glucose; DM, diabetes mellitus; MetS, metabolic syndrome.
aLog transformed, bCalculated by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation.
T3 | T1&T2 | P value | |
---|---|---|---|
Crude | 1 (reference) | 3.39 (1.22–9.44) | 0.019 |
Model 1 | 1 (reference) | 3.37 (1.21–9.40) | 0.020 |
Model 2 | 1 (reference) | 3.35 (1.20–9.38) | 0.021 |
Model 3 | 1 (reference) | 4.03 (1.37–11.87) | 0.012 |
Values are presented as odds ratio (95% confidence interval). Model 1: adjusted with age, and sex; Model 2: Model 1+alcohol drink, smoking, exercise; Model 3: Model 2+body mass index, waist circumference, systolic blood pressure, fasting blood glucose, estimated glomerular filtration rate, homeostatic model assessment for insulin resistancea, aspartate aminotransferasea, alanine aminotransferasea, and total cholesterol.
aLog transformed.